Amyotrophic Lateral Sclerosis ALS
Rilutek is expensive
$600-700 for a 30 day supply, but most insurance covers it
Diagnosis of ALS
-History -EMG -MRI and spinal fluid analysis -muscle biopsy -PFTs
impaired sleep treatment
-Nocturnal noninvasive positive-pressure ventilation (NIPPV) -Hospital bed -Mirtazapine -Melatonin
Novel therapies
-ceftriaxone - may possess antiexitotoxic properties (phase III trial) -stem cell therapies -electrical diaphragmatic pacemaker
Fatigue treatment
-personal plan of care -PT/OT to home for modifications -exercise and mobility program -special equipment
___ % live longer than 10 years
10
ALS hereditary
10% FALS (familial ALS)
___ % survive 5 years
20
Around 60% of ALS patient die within
24 hours of deterioration
% of ALS clients that die within ____ months of diagnosis
50 18
Rilutek Dosage:
50 mg po every 12 hours
Palliative care and Hospice
All ALS care is currently palliative
ALS - connection between muscle and
CNS is blocked muscle begins to atrophy
Amyotrophic Lateral Sclerosis ALS also known as
Charcot's disease Lou Gehrig's disease
done to diagnose abnormal electrical activity of involved skeletal muscles
Electromyography (EMG)
Early symptoms of ALS
Fasciculations (twitching) of the face Dysarthria (slurred speech) (80% of pts) Dysphagia (difficulty swallowing) Limb weakness ( 65%)
Who gets ALS
all races Men 40-70 yrs of age (avg 55-65 yrs)
Light-tech device:
alphabet boards, individual picture communication charts, picture symbols, telephone communication systems
treatment for cognitive decline and depression
amitriptyline or SSRI depressants
Muscle biopsy demonstrate small,
angulated atrophic fibers
spasticity treatment
baclofen dantrolen sodium
Sialorrhoea: ( An excessive secretion of saliva)
caused by inability to swallow well, but patients will have increased saliva—50% patients; can lead to aspiration pneumonia
treatment for emotional liability
dextromethorphan hydrobromide quinidine sulphate
common progression -
difficulty walking,cane-walker-wchr lose ability to write, type, feed self difficulty speaking/swallowing -----may need feeding tube---- decrease in lung capacity (<50%=vent) progression can be 6 yrs or many yrs
constipation treatment
docusate - lactulose increased fluid/dietary fiber enema
In familial ALS, the disease is autosomal ______: if a parent has ALS the offspring have______ a chance of inheriting the gene, not all people with ALS gene will develop the disease.
dominant 50%
• Symptoms of ____ may not be evident until about 80% of the motor neurons are lost • Defective articulation • Slow laborious speech • Imprecise consonant production • Marked hypernasality
dysarthria
Rilutek should be taken on an
empty stomach same time each day
ALS causes (unknown) or
excess of a neurotransmitter called glutamate builds up in the synapse causing eventual nerve cell death and subsequent muscle atrophy of the muscle attached to that nerve -or autoimmune problem
MRI of brain and cervical region done to
exclude other conditions
Rilutek common S/E
fatigue somnolence N/D dizzy May cause increased liver enzymes
Cognitive symptoms in ALS are usually due to
frontotemporal impairment and include personality change, irritability, obsessions, poor insight and impairment in language
Depression & anxiety are more common in patients who are at___________________ (about half of caregivers deal with anxiety). However recent study showed severe depression in <20% of patients with ALS as compared to 40-50% of patients with other neurodegenerative motor conditions such as MS, Parkinson's and Huntington's however 50% of patients with ALS struggled with some depression
high age at onset of the disease
Other "mimicking" disorders include:
hyperthyroidism, hypoglycemia, compression of the spinal cord, toxic agents, infections.
Amyotrophic Lateral Sclerosis ALS is an
incurable fatal neuromuscular disease characterized by progressive muscle weakness, resulting in paralysis. It is characterized by rapid deterioration and the selective death of motor neurons in the cerebral cortex, brainstem, and spinal cord
Motor neurons, which control the movement of voluntary muscles, deteriorate and eventually die. When the motor neurons die, the brain can no longer
initiate and control muscle movement. Because muscles no longer receive the messages they need in order to function, they gradually weaken and deteriorate.
ALS patients retain full
intellectual capacity and intelligence However, approximately 15% will develop dementia
Altered communication
light-tech device electronic high-tech device
Urinary urgency can occur especially with those with
lower extremity spasticity
pain for ALS palliative/hospice care
morphine fentanyl
PFTs(Pulmonary function tests): reveal
motor strength deficits such as decreased vital capacity
Early stages of the disease involve surviving motor neurons "sprouting"
new branches (similar to cardiac collateral flow!!) to reinnervate affected muscle fibers in an attempt to preserve muscle strength. However, as the disease progresses the reinnervation fails.
ethical issues involving passing disease
onto children. May not even know you have it til after family is started
Spinal fluid may be done to rule out
other causes
urinary urgency treatment
oxybutynin voiding schedule superpubic catheter
Electronic high-tech devices:
portable amplifiers that increase the patients volume, digital recorders that playback prerecorded words and phrases on command, dedicated voice synthesizers. Speech synthesis software if available for use in laptops. Brain-computer interface communication devices for individuals with advanced ALS .
Pneumovax immunization and yearly influenza immunization help reduce
pulmonary infections
Noisy breathing: atropine helps control
rattily breathing with those who have reduced ability to cough (morphine also given)
most common cause of death ALS
respiratory failure or cardiac arrhythmias due to insufficient oxygenation
impaired sleep maybe from
respiratory insufficiency, difficulty repositioning in bed, pain, anxiety and depression
Riluzole (Rilutek): antiglutamate: 1st drug developed to treat ALS
slows progression of disease by inhibiting release of GLUTAMIC acid in the CNS and protects the neurons
Environmental factors contributing to ALS
smoking exposure to agricultural chemicals and solvents
pain treatment
stretching and ROM exercises support hose NSAIDS and opioids Vitamin E and C (may reduce cramping)
treatment for Sialorrhoea
transdermal scopolamine injections of botulinum toxin
symptoms of ALS
tripping, stumbling, falling lose muscle control/strength n hands/arms difficulty breathing chronic fatigue muscle twitching/cramping
Emotional liability:
uncontrolled laughter or crying, often with minimal provocation and maybe inappropriate to the context of situation
_____ dependent ALS clients may live for many years
ventilator
Respiratory infection (pneumonia) increases as
weakened diaphragm and chest muscles make it difficult to clear lung secretions
Diagnosis typically takes________ process of eliminating other disorders
weeks or months,
________ in about 65% of patients: foot drop, difficulty walking , loss of hand dexterity or shoulder weakness
• Limb weakness